Project Number 5R01AG061898-03 Agency/Funding Organization NIA Funding Year 2021 View Full Project Details for First-in-human SAD & MAD trials for MW151, a novel Alzheimer's disease drug candidate that attenuates proinflammatory cytokine dysregulation Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) f. Inflammation Researcher and Organization Principal Investigator VAN ELDIK, LINDA J Principal Investigator First Name LINDA Principal Investigator Last Name VAN ELDIK Awardee Organization UNIVERSITY OF KENTUCKY Awardee State Kentucky Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-18-175: Pilot Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01 Clinical Trial Optional) FY Overall Cost $1,193,602 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M
